BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 105067)

  • 1. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Shedd DG
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
    J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    Edwards KM; Gewurz H; Lint TF; Mold C
    J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T; Verbrugh HA; Verhoef J
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
    Bjornson AB; Altemeier WA; Bjornson HS
    Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M; Valdimarsson H
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ; Hastings MJ; Easmon CS; Cole PJ
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
    van Bronswijk H; Verbrugh HA; Heezius HC; Renders NH; Fleer A; van der Meulen J; Oe PL; Verhoef J
    Immunology; 1989 May; 67(1):81-6. PubMed ID: 2737697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.